(19)
(11) EP 3 354 232 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.05.2022 Bulletin 2022/21

(45) Mention of the grant of the patent:
06.04.2022 Bulletin 2022/14

(21) Application number: 18161459.5

(22) Date of filing: 30.01.2009
(51) International Patent Classification (IPC): 
A61F 2/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61F 2/12; A61F 2250/0004

(54)

BREAST IMPLANT SYSTEM

BRUSTIMPLANTATSYSTEM

SYSTÈME D'IMPLANT MAMMAIRE

(84) Designated Contracting States:
BE CH DE FR GB LI NL SE

(30) Priority: 31.01.2008 US 6807

(43) Date of publication of application:
01.08.2018 Bulletin 2018/31

(60) Divisional application:
22160751.8

(62) Application number of the earlier application in accordance with Art. 76 EPC:
13189964.3 / 2689747
09705732.7 / 2247260

(73) Proprietor: Implantica Patent Ltd.
223 70 Lund (SE)

(72) Inventor:
  • Forsell, Peter
    6300 Zug (CH)

(74) Representative: Klunker IP Patentanwälte PartG mbB 
Destouchesstraße 68
80796 München
80796 München (DE)


(56) References cited: : 
EP-A1- 0 357 927
WO-A1-97/40749
WO-A2-2007/004213
US-A- 5 723 006
 WO-A1-96/40003
WO-A2-2006/034273
US-A- 4 507 810
US-A1- 2003 074 084
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).